Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Gleevec® (imatinib) – New warning
September 6, 2017 – The FDA approved an update to the Warnings and Precautions section of the Gleevec (imatinib) drug label regarding the risk of renal toxicity.
